Financials

  • Market Capitalization N/A
  • Employee 171
  • Founded 2019
  • CEO N/A
  • Website www.iambic.ai
  • Headquarter Delaware, United States
  • FIGI BBG011RJ5Z57
  • Industry N/A

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
6956
BMMX
Black Mammoth Metals Corporation Common Shares
2.33 USD-8.27%-10.04%-22.85%-31.47%0 USD
6957
GANZ
22.0500 USD-2.00%-2.00%-9.39%-10.18%0 USD
6959
SMRZ
15.8600 USD-7.95%-12.86%-24.60%-29.39%0 USD
6960
WBEM
19.4200 USD-5.41%-8.95%-16.44%-18.47%0 USD

Frequently asked questions about Iambic Therapeutics, Inc. Common Stock

What is the Iambic Therapeutics, Inc. Common Stock stock price today?

The current price of Iambic Therapeutics, Inc. Common Stock (IAM) is 13.11. Over the past 24 hours, the stock has changed by -8.06%. Follow the IAM chart for real-time price dynamics.

What is the stock ticker of Iambic Therapeutics, Inc. Common Stock?

Iambic Therapeutics, Inc. Common Stock trades under the ticker IAM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Iambic Therapeutics, Inc. Common Stock stock going up?

IAM has changed by +3.31% over the last week, -14.87% over the last month, and -18.82% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Iambic Therapeutics, Inc. Common Stock?

Iambic Therapeutics, Inc. Common Stock currently has a market capitalization of 0. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Iambic Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Iambic Therapeutics, Inc. Common Stock reported earnings of -8.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Iambic Therapeutics, Inc. Common Stock revenue for the last quarter?

Iambic Therapeutics, Inc. Common Stock reported quarterly revenue of 11.35 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

How many employees does Iambic Therapeutics, Inc. Common Stock have?

As of the latest available data, Iambic Therapeutics, Inc. Common Stock has 171 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Iambic Therapeutics, Inc. Common Stock stock?

You can buy Iambic Therapeutics, Inc. Common Stock (IAM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Iambic Therapeutics, Inc. Common Stock stock?

Investing in Iambic Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IAM chart and related analysis on metatrader.com as part of your research.